While the start of 2022 brought uncertainty in the orthopedics space due to a drop off in the demand as facilities canceled or delayed elective procedures, the sector has since made significant strides, MD+DI reports. M&A and development of new technologies has led activities in orthopedics. M&As remained an active strategy in 2022, with differing deal structures. The year’s major deals included an acquisition of CrossRoads Extremity Systems by Depuy Synthes, adding to the latter’s foot and ankle surgery portfolio. Read more.
Orthopedic M&A Shine in 2022
